Spero therapeutics to present at the ladenburg thalmann healthcare conference

Cambridge, mass., july 07, 2021 (globe newswire) -- spero therapeutics, inc. (nasdaq: spro), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that ankit mahadevia, m.d., president and chief executive officer of spero therapeutics, will give a corporate presentation and be available for virtual one-on-one meetings at the ladenburg thalmann healthcare conference, taking place virtually from july 13 – 14, 2021. details for the presentation are as follows:
SPRO Ratings Summary
SPRO Quant Ranking